Alembic Ltd Q4 FY26: Profit Plunge and Margin Compression Signal Operational Headwinds

The March 2026 quarter results paint a picture of operational strain, with both revenue and profitability metrics declining sequentially and year-on-year. Whilst the consolidated profit showed marginal resilience with a 11.64% quarter-on-quarter improvement, the standalone business bore the brunt of deteriorating operational efficiency. The company's operating margin excluding other income fell to its lowest point in the trailing eight quarters at 33.66%, down from 45.35% in Q4 FY25, signalling significant cost pressures or pricing headwinds.

Investors reacted negatively to the weak results, with the stock declining 2.96% on the results day and continuing to trade below all major moving averages. The share price has fallen 21.81% over the past year, significantly underperforming both the Sensex (down 7.23%) and the broader realty sector (up 12.76%). At current levels of ₹87.30, the stock trades 30.55% below its 52-week high of ₹125.70 reached in August 2025.

Financial Performance: Revenue Stagnation and Margin Erosion

Alembic's Q4 FY26 standalone revenue of ₹60.04 crores remained virtually flat year-on-year, declining marginally by 0.38% from ₹60.27 crores in Q4 FY25. The sequential decline was more pronounced at 19.24%, falling from ₹74.34 crores in Q3 FY26. This revenue volatility across quarters suggests inconsistent business momentum, particularly concerning given the company's operations in both pharmaceuticals and real estate—sectors that typically demonstrate more stable revenue patterns.

The most alarming aspect of Q4 FY26 results was the severe margin compression. Operating profit before depreciation, interest, and tax (excluding other income) fell to ₹20.21 crores from ₹27.33 crores in the year-ago quarter, representing a 26.05% year-on-year decline. Operating margin excluding other income contracted by a massive 1,169 basis points year-on-year to 33.66%, the lowest level recorded in the trailing two years. Quarter-on-quarter, margins fell 325 basis points from 36.91% in Q3 FY26.

Employee costs surged 80.62% year-on-year to ₹11.74 crores in Q4 FY26 from ₹6.50 crores in Q4 FY25, and increased 13.76% sequentially from ₹10.32 crores in Q3 FY26. This sharp escalation in personnel expenses, without commensurate revenue growth, directly impacted profitability. The company's profit after tax margin collapsed to 16.01% in Q4 FY26 from 39.41% in the year-ago quarter—a staggering 2,340 basis point deterioration.

An unusual aspect of the quarter was the abnormally high tax rate of 47.89%, significantly above the company's historical average of 10.92% and well above the statutory corporate tax rate. This resulted in a tax outgo of ₹8.83 crores on a profit before tax of ₹18.44 crores. In comparison, Q3 FY26 saw a more normalised tax rate of 12.77%. The elevated tax provision in Q4 FY26 further compressed bottom-line performance, though the underlying operational weakness remains the primary concern.

Operational Challenges: Weak Returns and Capital Efficiency

Alembic's return metrics reveal fundamental challenges in capital deployment and operational efficiency. The company's average return on equity (ROE) stands at 11.41%, which whilst positive, falls below the peer group average and indicates suboptimal profitability relative to shareholder capital. More concerning is the average return on capital employed (ROCE) of just 1.68%, suggesting the company generates minimal returns on the total capital invested in the business. The latest ROCE of 3.47% shows marginal improvement but remains anaemic by any standard.

The company's balance sheet as of March 2025 shows shareholder funds of ₹2,338.59 crores, comprising share capital of ₹51.36 crores and reserves of ₹2,287.23 crores. Investments dominate the asset side at ₹2,118.52 crores, representing 90.59% of shareholder funds. Fixed assets stood at ₹135.38 crores, whilst current assets totalled ₹204.87 crores. The company maintains minimal debt with long-term borrowings of just ₹10.67 crores, resulting in a net cash position with average net debt to equity of negative 0.03.

Whilst the debt-free status is a positive, the massive investment book relative to operating assets suggests Alembic functions more as a holding company than an active operating business. The company's sales to capital employed ratio of 0.06x is exceptionally low, indicating that for every rupee of capital deployed, the company generates just six paise of revenue. This points to significant underutilisation of assets or a business model heavily dependent on investment income rather than operating activities.

The five-year financial track record shows impressive top-line growth, with sales compounding at 33.76% annually from ₹73.00 crores in FY21 to ₹221.00 crores in FY25. Operating profit (excluding other income) grew even faster at a 100.47% CAGR, rising from ₹11.00 crores to ₹93.00 crores over the same period. However, this growth has been inconsistent, and the Q4 FY26 results suggest momentum may be stalling.

The Other Income Puzzle: Investment-Driven Earnings Volatility

A striking feature of Alembic's financial profile is the outsized role of other income in driving profitability. In Q4 FY26, other income stood at ₹2.14 crores, relatively modest compared to operating profit of ₹20.21 crores. However, in Q3 FY25 (September quarter), other income surged to an extraordinary ₹64.92 crores, dwarfing the operating profit of ₹23.24 crores. Similarly, in Q3 FY24, other income reached ₹65.60 crores against operating profit of ₹19.58 crores.

On an annual basis, other income contributed ₹74.00 crores in FY25, representing 44.05% of total operating profit including other income of ₹168.00 crores. This heavy reliance on investment income—likely comprising dividend income, capital gains, and interest from the company's ₹2,118.52 crores investment portfolio—creates earnings volatility and makes the core operating business performance difficult to assess.

The consolidated results provide additional context. Consolidated net profit for Q4 FY26 stood at ₹67.13 crores, significantly higher than the standalone profit of ₹9.61 crores. This suggests subsidiaries or associates contributed approximately ₹57.52 crores to group profitability. The consolidated profit showed relative resilience, declining just 1.93% year-on-year compared to the 59.54% standalone decline, indicating that group entities partially cushioned the weak standalone performance.

Peer Comparison: Valuation Discount Despite Weak Fundamentals

Within the realty sector peer group, Alembic trades at a significant valuation discount across multiple metrics, though this discount appears justified given the company's weak operational performance and returns profile. The company's price-to-earnings ratio of 7.18x is the lowest in the peer set, well below the sector average of approximately 68x. However, this low multiple reflects market scepticism about earnings quality and sustainability rather than representing an attractive entry opportunity.

Alembic's return on equity of 11.41% trails peers like Elpro International (20.49%) and EFC India (20.17%), though it exceeds Arvind SmartSpaces (9.39%) and National Standard (6.15%). The company's price-to-book ratio of 0.90x—implying the stock trades below net asset value—is the second-lowest in the group, suggesting the market assigns minimal value to the company's earning power beyond its balance sheet assets.

The dividend yield of 2.80% is the highest amongst peers that pay dividends, reflecting the low stock price rather than generous payout policy. The company paid a dividend of ₹2.40 per share with an ex-dividend date of August 5, 2025, representing a conservative payout ratio of 19.84% of earnings. The debt-free balance sheet (negative 0.03 debt-to-equity) is a relative strength, matching Arvind SmartSpaces and bettering most peers.

However, the valuation discount is not unwarranted. Peers like Elpro International and EFC India command premium multiples due to superior ROE profiles and more consistent operational performance. Alembic's combination of low returns, high earnings volatility, and deteriorating quarterly trends justifies the market's cautious stance. The company ranks sixth in market capitalisation amongst the peer group at ₹2,244 crores, reflecting its small-cap status and limited institutional following.

Valuation Analysis: Expensive Despite Low Multiples

Despite trading at seemingly attractive low multiples, Alembic's overall valuation assessment is "Very Expensive" according to proprietary scoring models. This counterintuitive rating stems from the quality-adjusted valuation framework that considers not just absolute multiples but also growth sustainability, return on capital, and earnings consistency. The company's PEG ratio of 5.21 indicates the stock is expensive relative to its growth prospects, with investors paying ₹5.21 for every percentage point of earnings growth.

The company's enterprise value to EBITDA multiple of 22.70x and EV/EBIT of 25.82x appear elevated when considering the weak ROCE of 3.47% and inconsistent quarterly performance. The EV to sales ratio of 9.22x seems particularly rich for a business generating such modest returns on capital. The EV to capital employed ratio of 0.90x, whilst below 1.0x, still implies the market values the business at 90% of its total capital base despite the capital generating minimal returns.

The stock's valuation grade has oscillated between "Very Expensive" and "Risky" over the past several years, most recently shifting to "Very Expensive" from "Risky" on January 29, 2021. This persistent expensive rating despite low headline multiples reflects structural concerns about business quality, capital efficiency, and earnings sustainability. The market appears to be pricing in significant execution risk and limited growth visibility.

At the current price of ₹87.30, the stock trades 30.55% below its 52-week high of ₹125.70 but remains 23.58% above its 52-week low of ₹70.64. The book value per share stands at ₹91.07, implying the stock trades marginally below its net asset value. However, given the weak return on equity of 11.41%, this below-book valuation may still not represent compelling value, as the company's earning power does not justify even a 1.0x price-to-book multiple.

Shareholding Pattern: Stable Promoter Base, Declining Foreign Interest

Alembic's shareholding structure shows remarkable stability in promoter holding but a gradual decline in foreign institutional interest over the past five quarters. Promoter holding has remained rock-solid at 70.88% across all five quarters from March 2025 through March 2026, with no sequential changes. The promoter group, led by Nirayu Private Limited (63.06%) and the Amin family, demonstrates strong commitment to the company with zero pledging of shares—a positive signal for corporate governance.

However, the concerning trend is the steady erosion of foreign institutional investor (FII) holding, which has declined from 1.66% in March 2025 to 1.25% in March 2026—a cumulative reduction of 41 basis points over five quarters. The sequential decline of 3 basis points from December 2025 to March 2026 continues this negative trend. With 41 FII investors holding stakes, the gradual exit suggests growing disenchantment with the company's operational performance and return profile amongst sophisticated international investors.

The complete absence of mutual fund and insurance company holdings (both at 0.00%) is particularly striking and concerning. Domestic institutional investors—who typically conduct rigorous fundamental analysis—have chosen to avoid Alembic entirely, suggesting consensus scepticism about the investment case. Only one mutual fund holds a position, and the total institutional holding stands at a mere 1.30%, indicating the stock remains firmly in the retail and promoter domain.

Non-institutional investors (retail and HNIs) have gradually increased their holding from 27.41% to 27.82% over the five quarters, absorbing the shares sold by FIIs. This shift from institutional to retail ownership typically signals deteriorating investment quality, as retail investors often lack the analytical resources and risk management discipline of institutional players. The marginal 4 basis point quarter-on-quarter increase in non-institutional holding in Q4 FY26 continues this concerning trend.

Stock Performance: Persistent Underperformance Across Timeframes

Alembic's stock price performance has been disappointing across most timeframes, with the shares declining 21.81% over the past year compared to a 7.23% decline in the Sensex, resulting in a negative alpha of 14.58 percentage points. The underperformance is even more stark when compared to the realty sector, which gained 12.76% over the same period—a massive 34.57 percentage point underperformance by Alembic.

The short-term picture is equally bleak. The stock has declined 2.98% over the past week, 3.38% over the past month, and 7.03% over three months—all periods of underperformance relative to the broader market. Year-to-date, shares are down 13.62%, underperforming the Sensex by 200 basis points. The only silver lining appears in the three-year timeframe, where Alembic has returned 29.66%, outperforming the Sensex's 22.01% gain by 7.65 percentage points.

However, the five-year and ten-year returns paint a sobering picture of long-term value destruction. Over five years, the stock has declined 33.86% whilst the Sensex gained 51.96%—a massive 85.82 percentage point underperformance. The ten-year return of 144.54%, whilst positive in absolute terms, significantly lags the Sensex's 197.68% gain. These extended-period returns suggest fundamental issues with the business model and execution that have consistently disappointed investors.

From a risk-adjusted perspective, Alembic falls into the "Medium Risk Low Return" category with a one-year risk-adjusted return of negative 0.75 and volatility of 29.14%—more than double the Sensex's 13.01% volatility. The stock's beta of 1.42 indicates high sensitivity to market movements, amplifying both gains and losses. The negative Sharpe ratio reflects returns below the risk-free rate after adjusting for volatility, making the stock unattractive from a risk-return standpoint.

Technical Analysis: Mildly Bearish Trend with Multiple Resistance Levels

Technical indicators paint a predominantly negative picture for Alembic, with the overall trend classified as "Mildly Bearish" since April 15, 2026. The stock trades below all major moving averages, indicating sustained selling pressure and lack of buyer conviction. The current price of ₹87.30 sits below the 5-day moving average of ₹89.93, 20-day average of ₹92.03, 50-day average of ₹86.29, 100-day average of ₹91.33, and 200-day average of ₹97.29.

The immediate support level stands at ₹70.64, the 52-week low, representing a potential 19.06% downside from current levels. On the upside, the stock faces multiple resistance zones: immediate resistance at the 20-day moving average of ₹92.03, followed by the 100-day average at ₹91.33, the 200-day average at ₹97.29, and ultimately the 52-week high of ₹125.70. The clustering of moving averages between ₹91-97 creates a formidable resistance zone that the stock must decisively breach to signal trend reversal.

Weekly technical indicators present a mixed picture: MACD shows "Mildly Bullish" signals, suggesting potential short-term momentum, whilst Bollinger Bands indicate "Sideways" movement. The Relative Strength Index (RSI) provides no clear signal, indicating the stock is neither oversold nor overbought. On-balance volume (OBV) trends "Mildly Bullish" on a weekly basis, suggesting marginal buying interest, though the monthly OBV turns "Mildly Bearish."

Monthly indicators are more uniformly negative: MACD, Bollinger Bands, and KST all flash "Bearish" signals, indicating deteriorating medium-term momentum. Only Dow Theory shows "Mildly Bullish" on the monthly chart, providing limited counterbalance to the prevailing negative technical setup. The trend history shows the stock has oscillated between "Bearish" and "Mildly Bearish" since late August 2025, with no sustained bullish phases.

Delivery volume analysis reveals a 39.91% decline in average delivery volumes over the trailing month compared to the previous month, suggesting reduced conviction amongst buyers. The one-day delivery percentage of 51.07% is marginally above the five-day average of 49.05% but below the trailing one-month average of 48.70%, indicating mixed near-term sentiment. The decline in delivery volumes from an average of 1.97 lakh shares in the previous month to 1.19 lakh shares in the trailing month signals waning investor interest.

Investment Thesis: Quality Concerns Override Valuation Appeal

Alembic's investment case presents a complex picture where superficially attractive valuation metrics are undermined by fundamental quality concerns and deteriorating operational trends. The company's Mojo score of 35 out of 100 places it firmly in "SELL" territory, reflecting the confluence of negative factors across multiple dimensions of analysis.

The valuation paradox—trading at low multiples yet rated "Very Expensive"—stems from the company's poor capital efficiency and earnings quality. With an average ROCE of just 1.68% and latest ROCE of 3.47%, the business barely generates returns above risk-free rates. The PEG ratio of 5.21 indicates investors are paying a steep premium relative to sustainable growth prospects. The price-to-book ratio of 0.90x, whilst below net asset value, is not necessarily cheap given the ROE of only 11.41%.

The quality assessment of "Average" masks significant underlying weaknesses. Whilst the company benefits from zero debt and no promoter pledging, the operational metrics reveal a struggling business. The sales to capital employed ratio of 0.06x indicates massive underutilisation of assets or a holding company structure where investments dominate operating assets. The extreme volatility in other income—swinging from ₹2-3 crores in normal quarters to ₹65+ crores in investment gain quarters—creates unpredictable earnings and questions the sustainability of reported profits.

Key Strengths & Risk Factors

Outlook: What to Watch

The near-term outlook for Alembic remains challenging given the confluence of operational headwinds, weak return metrics, and negative technical momentum. The Q4 FY26 results represent a significant setback, with both revenue stagnation and severe margin compression raising questions about the sustainability of the business model. The abnormally high tax rate of 47.89% in Q4 FY26, whilst potentially a one-time aberration, further clouds the earnings picture.

For the investment case to improve materially, the company needs to demonstrate several quarters of consistent operational performance with margin recovery, improved capital efficiency, and reduced earnings volatility. The complete absence of domestic institutional investors and steady FII exit suggests sophisticated investors see limited near-term catalysts. Until the company addresses fundamental concerns around returns on capital and establishes a track record of stable, quality earnings, the stock is likely to remain in the "value trap" category—cheap on headline multiples but expensive relative to earning power and growth prospects.